Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Yokoi

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Scientific Reports|December 3, 2021
Clinical effects of cervical conization with positive margins in cervical cancerYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Gynecologic Oncology|April 19, 2023
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathwayXuboya Chang, Satoshi Tamauchi, Kosuke Yoshida, et al.
Japanese Journal of Clinical Oncology|November 6, 2019
Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysisMasato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, et al.
The FEBS Journal|October 11, 2011
Biological validation that SF3b is a target of the antitumor macrolide pladienolideAkira Yokoi, Yoshihiko Kotake, Kentaro Takahashi, et al.
Nature Communications|March 7, 2017
Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancerAkira Yokoi, Yusuke Yoshioka, Yusuke Yamamoto, et al.
Cell Reports|July 18, 2024
Aberrant regulation of serine metabolism drives extracellular vesicle release and cancer progressionTomofumi Yamamoto, Jun Nakayama, Fumihiko Urabe, et al.
Oncotarget|November 23, 2017
A combination of circulating miRNAs for the early detection of ovarian cancerAkira Yokoi, Yusuke Yoshioka, Akihiro Hirakawa, et al.
Cancer Science|April 3, 2014
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitorTakayuki Nakagawa, Tomohiro Matsushima, Satoshi Kawano, et al.
Oncology Letters|June 16, 2022
Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFsToshio Imai, Mie Naruse, Masako Ochiai, et al.
Current Oncology (Toronto, Ont.)|May 5, 2021
Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical CancerSatomi Hattori, Nobuhisa Yoshikawa, Kazumasa Mogi, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Scientific Reports|December 3, 2021
Clinical effects of cervical conization with positive margins in cervical cancerYukari Nagao, Akira Yokoi, Kosuke Yoshida, et al.
Gynecologic Oncology|April 19, 2023
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathwayXuboya Chang, Satoshi Tamauchi, Kosuke Yoshida, et al.
Japanese Journal of Clinical Oncology|November 6, 2019
Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysisMasato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, et al.
The FEBS Journal|October 11, 2011
Biological validation that SF3b is a target of the antitumor macrolide pladienolideAkira Yokoi, Yoshihiko Kotake, Kentaro Takahashi, et al.
Nature Communications|March 7, 2017
Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancerAkira Yokoi, Yusuke Yoshioka, Yusuke Yamamoto, et al.
Cell Reports|July 18, 2024
Aberrant regulation of serine metabolism drives extracellular vesicle release and cancer progressionTomofumi Yamamoto, Jun Nakayama, Fumihiko Urabe, et al.
Oncotarget|November 23, 2017
A combination of circulating miRNAs for the early detection of ovarian cancerAkira Yokoi, Yusuke Yoshioka, Akihiro Hirakawa, et al.
Cancer Science|April 3, 2014
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitorTakayuki Nakagawa, Tomohiro Matsushima, Satoshi Kawano, et al.
Oncology Letters|June 16, 2022
Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFsToshio Imai, Mie Naruse, Masako Ochiai, et al.
Current Oncology (Toronto, Ont.)|May 5, 2021
Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical CancerSatomi Hattori, Nobuhisa Yoshikawa, Kazumasa Mogi, et al.
Pageof 14